Tech Company Financing Transactions

Calistoga Pharmaceuticals Funding Round

Calistoga Pharmaceuticals secured a $21 million funding round on 3/6/2007. Investors included Frazier Healthcare Partners, Alta Partners and Amgen Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

2101 - 4th Ave. 1960
Seattle, WA 98121
USA

Phone

(206) 728-4700

Website

www.calistogapharma.com

Email Address

[email protected]

Overview

Calistoga Pharmaceuticals, is developing a drug candidate acquired from Icos that has potential to treat various forms of cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Carol Gallagher

        

Chief Financial Officer

Andrew Guggenhime

        

Chief Medical Officer

Albert Yu

        

VP - R & D

Langdon Miller

        

Browse more venture capital transactions:

Prev: 3/6/2007: Covario venture capital transaction
Next: 3/6/2007: VentiRx Pharmaceuticals venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary